{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20070910",
          "submission_public_notes": "Please see <a href=\"https://www.fda.gov/STIC/\">www.fda.gov/STIC</a> for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "8300",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/050792s002ltr.pdf",
              "date": "20070911",
              "type": "Letter"
            },
            {
              "id": "18263",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050792s002lbl.pdf",
              "date": "20070911",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20040729",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "18262",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50792lbl.pdf",
              "date": "20040802",
              "type": "Label"
            },
            {
              "id": "22242",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/050792s000_Duplex_ContainerTOC.html",
              "date": "20060728",
              "type": "Review"
            },
            {
              "id": "30563",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50792ltr.pdf",
              "date": "20040802",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA050792",
      "sponsor_name": "B BRAUN",
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFOTAXIME SODIUM",
              "strength": "EQ 2GM BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFOTAXIME SODIUM",
              "strength": "EQ 1GM BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}